and cyclic enol ethers which have been used widely in this
MCR (A, Scheme 1), the introduction of enamine-type
Scheme 1. Enol Ethers and Enamides in Povarov MCRs
Figure 1. Unsaturated lactams used in this study.
The first experiment involved the interaction of the
unsaturated lactam 1a, with p-toluidine and ethyl glyoxalate
under Sc(OTf)3 catalysis11,6b in the presence of 4 Å molecular
sieves in acetonitrile at room temperature. After chromato-
graphic purification, the tetrahydroquinolines 4a and 4a′ were
isolated (isomer ratio 4/3) in 43% overall yield (Scheme 2).
functional groups has been successfully exploited.2,6 In this
context, cyclic enamides are specially appealing since they
allow access to a new set of functionalized tetrahydroquino-
lines B.7 Importantly, the development of this chemistry by
Batey has allowed a straightforward synthesis of the alkaloids
Martinelline and Martinellic acid.7a-c The MCR adducts in
these processes show a normal connectivity pattern, thereby
leading to the expected tetrahydroquinolines. In sharp
contrast, when cyclic enol esters were tested in Povarov-
type conditions, the N-aryl lactams C were obtained.8 The
origin of these compounds may lie in the intramolecular
interception of the activated cationic intermediate by the
nucleophilic aniline nitrogen, which overrides the usual
aromatic electrophilic substitution. Here we studied the chem-
istry of unsaturated lactams in Povarov processes to determine
their synthetic usefulness and to establish the mechanistic trends
of these substrates in the MCR (Scheme 1).
Several unsaturated lactams were prepared by known
methods (or modifications thereof), usually from the corre-
sponding N-substituted imides by a reduction-elimination
sequence.9 The set included six- and seven-membered rings,
displaying distinct substituents at the nitrogen atom and also
at the neighboring position (1a-f, Figure 1). The pyrrolidone
derivative 1g with an exo double bond was also considered.10
Scheme 2. Povarov MCR with Unsaturated Lactam 1a
The stereochemical assignment of compounds 4a-4a′ was
performed by spectroscopical means. The low stereoselec-
tivity observed is the usual outcome in these processes.2
Next we examined the scope of the reaction, regarding
all the components (Table 1). The aniline input showed
Table 1. Scope of the Povarov MCR with Unsaturated Lactams
(6) (a) Lavilla, R.; Bernabeu, M. C.; Carranco, I.; Diaz, J. L. Org. Lett.
2003, 5, 717–720. (b) Carranco, I.; Diaz, J. L.; Jimenez, O.; Vendrell, M.;
Albericio, F.; Royo, M.; Lavilla, R. J. Comb. Chem. 2005, 7, 33–41
.
overall isomer
(7) (a) Batey, R. A.; Simoncic, P. D.; Smyj, R. P.; Lough, A. J. Chem.
Commun. 1999, 651–652. (b) Batey, R. A.; Powell, D. A. Chem. Commun.
2001, 2362–2363. (c) Powell, D. A.; Batey, R. A. Org. Lett. 2002, 4, 2913–
2916. (d) Hadden, M.; Nieuwenhuyzen, M.; Osborne, D.; Stevenson, P. J.;
Thompson, N.; Walker, A. D. Tetrahedron 2006, 62, 3977–3984. (e) Xia,
C.; Heng, L.; Ma, D. Tetrahedron Lett. 2002, 43, 9405–9409. (f) Stevenson,
P. J.; Graham, I. ARKIVOC (Vii). 2003, 139–144. (g) Hadden, M.;
Nieuwenhuyzen, M.; Potts, D.; Stevenson, P. J.; Thompson, N. Tetrahedron
2001, 57, 5615–5624.
yield
(%)
ratio
(4/4′)
entry
n
R1
R3
Me
R4
compound
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
2
Bn
Bn
H
CO2Et
CO2Et 2-furyl
4a-4a′
4b
43
38
42
33
42
64
61
56
35
4/3
1/-
3/2
1/-
1/1
1/1
8/5
5/8
3/2
OMe
F
OMe
Me
3-pyridyl 4c-4c′
H
2-furyl
4d
Bu
Bn
4-CF3-Ph 4e-4e′
(8) Isambert, N.; Cruz, M.; Arevalo, M. J.; Gomez, E.; Lavilla, R. Org.
Lett. 2007, 9, 4199–4202.
4-Cl-Ph
CO2Et
4-Cl-Ph
CO2Et
4f-4f′
4g-4g′
4h-4h′
4i-4i′
4-Me-Ph Me
(9) (a) Galbo, F. L.; Occhiato, E. G.; Guarna, A.; Faggi, C. J. Org.
Chem. 2003, 68, 6360–6368. (b) Bennett, D. J.; Blake, A. J.; Cooke, P. A.;
Godfrey, C. R. A.; Pickering, P. L.; Simpkins, N. S.; Walker, M. D.; Wilson,
C. Tetrahedron 2004, 60, 4491–4511. (c) Raheem, I. T.; Thiara, P. S.;
Peterson, E. A.; Jacobsen, E. N. J. Am. Chem. Soc. 2007, 129, 13404–
13405. (d) Hubert, J. C.; Wijnberg, J. B. P. A.; Speckamp, W. N.
Tetrahedron 1975, 31, 1437–1441. (e) Khan, M. M.; Melmon, K. L.; Egli,
M.; Lok, S.; Goodman, M. J. Med. Chem. 1987, 30, 2115–2120. (f)
Yoshifuji, S.; Arakawa, Y.; Nitta, Y. Chem. Pharm. Bull. 1987, 35, 357–
363.
H
H
Me
Me
appropriate reactivity, ranging from deactivated to activated
derivatives (entries 1-4). Also, the carbonyl range included
(11) (a) Kobayashi, S.; Sugiura, M.; Kitagawa, H.; Lam, W. W. L. Chem.
ReV. 2002, 102, 2227–2302. (b) Kobayashi, S. Eur. J. Org. Chem. 1999,
(10) Padwa, A.; Rashatasakhon, P.; Rose, M. J. Org. Chem. 2003, 68,
5139–5146.
15–27
.
Org. Lett., Vol. 12, No. 4, 2010
861